These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23829255)

  • 1. Conflicting information from TGA versus FDA may undermine compliance with use of medication.
    Beckmann KM
    Med J Aust; 2013 Jul; 199(1):28-9. PubMed ID: 23829255
    [No Abstract]   [Full Text] [Related]  

  • 2. A review of the rationale and clinical utilization of α2-adrenoceptor agonists for the treatment of attention-deficit/hyperactivity and related disorders.
    Sallee F; Connor DF; Newcorn JH
    J Child Adolesc Psychopharmacol; 2013 Jun; 23(5):308-19. PubMed ID: 23782125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating ADHD in Prison: Focus on Alpha-2 Agonists (Clonidine and Guanfacine).
    Mattes JA
    J Am Acad Psychiatry Law; 2016 Jun; 44(2):151-7. PubMed ID: 27236168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [α2-Adrenergic agonists, and drugs for ADHD].
    Clement HW; Schulz E
    Pharm Unserer Zeit; 2011 Nov; 40(6):503-9. PubMed ID: 22028136
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA approves nonopioid medication for managing opioid withdrawal.
    Traynor K
    Am J Health Syst Pharm; 2018 Jul; 75(13):927. PubMed ID: 29941528
    [No Abstract]   [Full Text] [Related]  

  • 6. Clonidine extended-release in attention-deficit hyperactivity disorder: profile report.
    Croxtall JD
    CNS Drugs; 2012 Mar; 26(3):277-9. PubMed ID: 22248146
    [No Abstract]   [Full Text] [Related]  

  • 7. Sapophagia (compulsive soap eating) and attention-deficit/hyperactivity disorder in a child responsive to clonidine.
    Saddichha S; Vibha P; Vishnuvardhan G
    J Clin Psychopharmacol; 2012 Apr; 32(2):291. PubMed ID: 22388159
    [No Abstract]   [Full Text] [Related]  

  • 8. A review of the use of clonidine as a sleep aid in the child and adolescent population.
    Nguyen M; Tharani S; Rahmani M; Shapiro M
    Clin Pediatr (Phila); 2014 Mar; 53(3):211-6. PubMed ID: 24027233
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis.
    Cortese S; Adamo N; Mohr-Jensen C; Hayes AJ; Bhatti S; Carucci S; Del Giovane C; Atkinson LZ; Banaschewski T; Simonoff E; Zuddas A; Barbui C; Purgato M; Steinhausen HC; Shokraneh F; Xia J; Cipriani A; Coghill D;
    BMJ Open; 2017 Jan; 7(1):e013967. PubMed ID: 28073796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing patterns of alpha agonist medication use in children and adolescents 2009-2011.
    Fiks AG; Mayne SL; Song L; Steffes J; Liu W; McCarn B; Margolis B; Grimes A; Gotlieb E; Localio R; Ross ME; Grundmeier RW; Wasserman R; Leslie LK
    J Child Adolesc Psychopharmacol; 2015 May; 25(4):362-7. PubMed ID: 25919708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis.
    Cortese S; Adamo N; Del Giovane C; Mohr-Jensen C; Hayes AJ; Carucci S; Atkinson LZ; Tessari L; Banaschewski T; Coghill D; Hollis C; Simonoff E; Zuddas A; Barbui C; Purgato M; Steinhausen HC; Shokraneh F; Xia J; Cipriani A
    Lancet Psychiatry; 2018 Sep; 5(9):727-738. PubMed ID: 30097390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA-approved drugs to treat ADHD.
    J Psychosoc Nurs Ment Health Serv; 2012 Mar; 50(3):11-2. PubMed ID: 22390784
    [No Abstract]   [Full Text] [Related]  

  • 13. Clonidine.
    St Dennis C; Synoground G
    J Sch Nurs; 1995 Dec; 11(4):9-12. PubMed ID: 8704379
    [No Abstract]   [Full Text] [Related]  

  • 14. Guanfacine extended-release (intuniv) for ADHD.
    Med Lett Drugs Ther; 2010 Oct; 52(1349):82-3. PubMed ID: 21045757
    [No Abstract]   [Full Text] [Related]  

  • 15. Does the increasing placebo response impact outcomes of adult and pediatric ADHD clinical trials? Data from the US Food and Drug Administration 2000-2009.
    Khan A; Fahl Mar K; Brown WA
    J Psychiatr Res; 2017 Nov; 94():202-207. PubMed ID: 28755620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clip & save: drug chart. FDA-approved drugs to treat ADHD.
    J Psychosoc Nurs Ment Health Serv; 2010 Mar; 48(3):9-10. PubMed ID: 20302260
    [No Abstract]   [Full Text] [Related]  

  • 17. Clonidine for treatment of attention-deficit/hyperactivity disorder.
    Med Lett Drugs Ther; 1996 Dec; 38(989):109-10. PubMed ID: 8957471
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA-Approved Drugs to Treat ADHD.
    J Psychosoc Nurs Ment Health Serv; 2019 Mar; 57(3):5-6. PubMed ID: 30835794
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment patterns, adherence, and persistence in ADHD: a Canadian perspective.
    Lachaine J; Beauchemin C; Sasane R; Hodgkins PS
    Postgrad Med; 2012 May; 124(3):139-48. PubMed ID: 22691908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing attention-deficit/hyperactivity disorder in children and adolescents.
    McClain EK; Burks EJ
    Prim Care; 2015 Mar; 42(1):99-112. PubMed ID: 25634708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.